This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Milam, J. E.
Right arrow Articles by Toews, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Milam, J. E.
Right arrow Articles by Toews, G. B.

 Previous Article  |  Next Article 

Infection and Immunity, October 2007, p. 4951-4958, Vol. 75, No. 10
0019-9567/07/$08.00+0     doi:10.1128/IAI.00176-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Modulation of the Pulmonary Type 2 T-Cell Response to Cryptococcus neoformans by Intratracheal Delivery of a Tumor Necrosis Factor Alpha-Expressing Adenoviral Vector{triangledown} ,{dagger}

Jami E. Milam,1 Amy C. Herring-Palmer,1 Raj Pandrangi,1 Roderick A. McDonald,1 Gary B. Huffnagle,1,2* and Galen B. Toews1

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine,1 Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 481092

Received 1 February 2007/ Returned for modification 11 March 2007/ Accepted 13 July 2007

C57BL/6 mice develop an allergic bronchopulmonary mycosis following intratracheal inoculation of Cryptococcus neoformans 24067. We determined that only low levels of tumor necrosis factor alpha (TNF-{alpha}) are produced in the lungs following infection. Thus, the objective of the present studies was to determine whether treatment with a TNF-{alpha}-expressing adenoviral vector (adenoviral vector with the murine TNF-{alpha} transgene under the control of the human cytomegalovirus promoter [AdTNF{alpha}]) could switch the type 2 (T2) T-cell response/T1 T-cell response balance toward the T1 T-cell response. AdTNF{alpha} induced an increase in TNF-{alpha} expression at days 3 and 7. At days 7 to 14, the number of cryptococcal lung CFU continued to increase in both untreated and control adenoviral vector (empty adenovirus type 5 backbone)-treated mice, but the number was ultimately 100-fold lower following AdTNF{alpha} treatment. AdTNF{alpha} markedly increased neutrophil and macrophage numbers, and pulmonary eosinophilia did not develop. CXCL1, CXCL2, and gamma interferon were also up-regulated, while eotaxin, interleukin-4 (IL-4), and IL-5 were down-regulated. AdTNF{alpha} treatment also increased the number of CD80+ and CD40+ cells and decreased the number of CD86+ cells (CD11b+ and CD11c+) in the lungs. Major histocompatibility complex class II levels on CD11b+ cells were increased. Whole-lung expression of inducible nitric oxide synthase was increased, while YM2 expression and acidic mammalian chitinase expression were decreased. None of these effects were observed with the control (empty) adenoviral vector. Overall, these results support the hypothesis that early TNF-{alpha} expression promotes a shift in T-cell and macrophage polarization from T2/alternatively activated macrophages toward T1/classically activated macrophages, resulting in control of the fungal infection and prevention of the allergic response.

* Corresponding author. Mailing address: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109-0642. Phone: (734) 936-9369. Fax: (734) 764-2665. E-mail: ghuff{at}umich.edu

{triangledown} Published ahead of print on 23 July 2007.

{dagger} Supplemental material for this article may be found at http://iai.asm.org/.

Editor: A. Casadevall

Infection and Immunity, October 2007, p. 4951-4958, Vol. 75, No. 10
0019-9567/07/$08.00+0     doi:10.1128/IAI.00176-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Osterholzer, J. J., Surana, R., Milam, J. E., Montano, G. T., Chen, G.-H., Sonstein, J., Curtis, J. L., Huffnagle, G. B., Toews, G. B., Olszewski, M. A. (2009). Cryptococcal Urease Promotes the Accumulation of Immature Dendritic Cells and a Non-Protective T2 Immune Response within the Lung. Am. J. Pathol. 174: 932-943 [Abstract] [Full Text]  
  • Stenzel, W., Muller, U., Kohler, G., Heppner, F. L., Blessing, M., McKenzie, A. N.J., Brombacher, F., Alber, G. (2009). IL-4/IL-13-Dependent Alternative Activation of Macrophages but Not Microglial Cells Is Associated with Uncontrolled Cerebral Cryptococcosis. Am. J. Pathol. 174: 486-496 [Abstract] [Full Text]  
  • Guillot, L., Carroll, S. F., Homer, R., Qureshi, S. T. (2008). Enhanced Innate Immune Responsiveness to Pulmonary Cryptococcus neoformans Infection Is Associated with Resistance to Progressive Infection. Infect. Immun. 76: 4745-4756 [Abstract] [Full Text]  
  • Chen, G.-h., McNamara, D. A., Hernandez, Y., Huffnagle, G. B., Toews, G. B., Olszewski, M. A. (2008). Inheritance of Immune Polarization Patterns Is Linked to Resistance versus Susceptibility to Cryptococcus neoformans in a Mouse Model. Infect. Immun. 76: 2379-2391 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»